Dexcom
Dexcom is a Series A to Series D stage investment firm. It has made 5 investments. 83% of their portfolio is in Healthcare. Average disclosed round size is $53.1M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Unknown
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Signos | Unknown | $20M | May 2026 |
| Signos | Unknown | $20M | Jan 2026 |
 Oura | Series D | $200M | Dec 2024 |
 Phenomix Sciences | Series A | $5.5M | May 2024 |
| OOura Health | Series D | — | Jan 2024 |
 Epitel | Series A | $20M | — |
Top Co-Investors
GV2 shared
Dexcom Ventures2 shared
Fidelity Investments2 shared
Labcorp1 shared
Health2047 Capital Partners1 shared
Alumni Ventures1 shared
Health Catalyst Capital1 shared
Wavemaker Three-Sixty Health1 shared
MedMountain Ventures1 shared
OSF HealthCare1 shared
Alphabet Inc.1 shared
Last updated: 20 October 2026